• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GOECP/SEOR胸腺上皮肿瘤放射治疗指南。

GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours.

作者信息

Rico Mikel, Flamarique Sonia, Casares Cristina, García Tamara, López Miriam, Martínez Maribel, Serrano Javier, Blanco Manuel, Hernanz Raúl, de Ingunza-Barón Lourdes, Marcos Francisco José, Couñago Felipe

机构信息

Department of Radiation Oncology, Complejo Hospitalario de Navarra, Pamplona 31008, Navarra, Spain.

Department of Radiation Oncology, University Hospital Miguel Servet, Zaragoza 50009, Aragón, Spain.

出版信息

World J Clin Oncol. 2021 Apr 24;12(4):195-216. doi: 10.5306/wjco.v12.i4.195.

DOI:10.5306/wjco.v12.i4.195
PMID:33959475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8085511/
Abstract

Thymic epithelial tumours (TET) are rare, heterogeneous neoplasms that range from resectable indolent tumours to aggressive thymic carcinomas with a strong tendency to metastasize. The pathological diagnosis is complex, in part due to the existence of several different classification systems. The evidence base for the management of TETs is scant and mainly based on non-randomised studies and retrospective series. Consequently, the clinical management of TETs tends to be highly heterogenous, which makes it difficult to improve the evidence level. The role of technological advances in the field of radiotherapy and new systemic therapies in the treatment of TETs has received little attention to date. In the present clinical guidelines, developed by the GOECP/SEOR, we review recent developments in the diagnosis and classification of TETs. We also present a consensus-based therapeutic strategy for each disease stage that takes into consideration the best available evidence. These guidelines focus primarily on the role of radiotherapy, including recent advances, in the management of TETs. The main aim of this document is to promote the standardisation of clinical practice and lay the foundations for future studies to clarify the main unresolved questions related to the optimal management of TET.

摘要

胸腺上皮肿瘤(TET)是罕见的异质性肿瘤,范围从可切除的惰性肿瘤到具有强烈转移倾向的侵袭性胸腺癌。病理诊断很复杂,部分原因是存在几种不同的分类系统。TET管理的证据基础不足,主要基于非随机研究和回顾性系列研究。因此,TET的临床管理往往高度异质,这使得提高证据水平变得困难。放射治疗领域的技术进步和新的全身治疗方法在TET治疗中的作用迄今很少受到关注。在由GOECP/SEOR制定的本临床指南中,我们回顾了TET诊断和分类的最新进展。我们还针对每个疾病阶段提出了基于共识的治疗策略,该策略考虑了现有最佳证据。这些指南主要关注放射治疗在TET管理中的作用,包括最近的进展。本文件的主要目的是促进临床实践的标准化,并为未来研究奠定基础,以阐明与TET最佳管理相关的主要未解决问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/cbf51efd5f91/WJCO-12-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/1cc79229260b/WJCO-12-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/85716a5a7705/WJCO-12-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/1ebb40fc0de4/WJCO-12-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/cbf51efd5f91/WJCO-12-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/1cc79229260b/WJCO-12-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/85716a5a7705/WJCO-12-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/1ebb40fc0de4/WJCO-12-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9f1/8085511/cbf51efd5f91/WJCO-12-195-g004.jpg

相似文献

1
GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours.GOECP/SEOR胸腺上皮肿瘤放射治疗指南。
World J Clin Oncol. 2021 Apr 24;12(4):195-216. doi: 10.5306/wjco.v12.i4.195.
2
Postoperative radiotherapy for thymic epithelial tumors: a narrative review.胸腺上皮肿瘤的术后放疗:一项叙述性综述
Mediastinum. 2024 Jan 10;8:40. doi: 10.21037/med-23-38. eCollection 2024.
3
Radiotherapy for thymic epithelial tumours: a review.胸腺上皮肿瘤的放射治疗:综述
Transl Lung Cancer Res. 2021 Apr;10(4):2088-2100. doi: 10.21037/tlcr-20-458.
4
New findings on thymic epithelial tumors: Something is changing.胸腺上皮肿瘤的新发现:情况正在发生变化。
World J Clin Oncol. 2015 Oct 10;6(5):96-8. doi: 10.5306/wjco.v6.i5.96.
5
GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.GOECP/SEOR 恶性胸膜间皮瘤放射治疗临床指南
World J Clin Oncol. 2021 Aug 24;12(8):581-608. doi: 10.5306/wjco.v12.i8.581.
6
Systemic treatments for thymic tumors: a narrative review.胸腺肿瘤的全身治疗:一篇叙述性综述
Mediastinum. 2021 Sep 25;5:24. doi: 10.21037/med-21-11. eCollection 2021.
7
GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.GOECP/SEOR非小细胞肺癌放射治疗指南。
World J Clin Oncol. 2022 Apr 24;13(4):237-266. doi: 10.5306/wjco.v13.i4.237.
8
China Anti-Cancer Association Guidelines for the diagnosis, treatment, and follow-up of thymic epithelial tumors (2023).中国抗癌协会胸腺瘤诊断、治疗及随访指南(2023年版)
Mediastinum. 2024 Apr 29;8:27. doi: 10.21037/med-23-54. eCollection 2024.
9
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.真实环境下专家病理审查对胸腺瘤诊断和治疗的影响:一项 RYTHMIC 研究。
Eur J Cancer. 2021 Jan;143:158-167. doi: 10.1016/j.ejca.2020.11.011. Epub 2020 Dec 11.
10
Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.多学科肿瘤委员会决策在胸腺瘤术后放疗中的应用:来自 RYTHMIC 前瞻性队列研究的见解。
J Thorac Oncol. 2017 Nov;12(11):1715-1722. doi: 10.1016/j.jtho.2017.07.023. Epub 2017 Jul 31.

引用本文的文献

1
An extremely rare case of thymic carcinoma manifesting as a liver metastasis: a case report and literature review.一例极为罕见的以肝转移为表现的胸腺癌:病例报告及文献复习
Discov Oncol. 2025 Jul 8;16(1):1286. doi: 10.1007/s12672-025-02823-6.
2
Management of Advanced Thymoma Presenting with Myasthenia Gravis in a Resource-limited Setting: A Case Report.资源有限环境下伴重症肌无力的晚期胸腺瘤的管理:一例报告
Acta Med Philipp. 2025 Jan 15;59(1):110-115. doi: 10.47895/amp.vi0.8074. eCollection 2025.

本文引用的文献

1
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.容积调强弧形治疗与强度调制质子治疗胸腺瘤术后放疗的比较
J Cancer Res Clin Oncol. 2020 Sep;146(9):2267-2276. doi: 10.1007/s00432-020-03281-z. Epub 2020 Jun 8.
2
Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.美国胸腺瘤、胸腺癌和胸腺神经内分泌肿瘤发病率的趋势。
PLoS One. 2019 Dec 31;14(12):e0227197. doi: 10.1371/journal.pone.0227197. eCollection 2019.
3
Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study.
单臂、多中心、Ⅱ期临床试验:nivolumab 治疗不可切除或复发性胸腺癌:PRIMER 研究。
Eur J Cancer. 2019 May;113:78-86. doi: 10.1016/j.ejca.2019.03.012. Epub 2019 Apr 13.
4
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.质子协作组和佛罗里达大学质子治疗研究所前瞻性注册研究中复发性肺癌患者再次接受质子治疗的临床结果。
Pract Radiat Oncol. 2019 Jul-Aug;9(4):280-288. doi: 10.1016/j.prro.2019.02.008. Epub 2019 Feb 23.
5
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).胸腺瘤治疗的最佳实践:意大利胸腺瘤协作组(TYME)的立场文件。
Cancer Treat Rev. 2018 Dec;71:76-87. doi: 10.1016/j.ctrv.2018.10.001. Epub 2018 Oct 5.
6
Clinical implication of the new TNM classification of thymic malignancies.胸腺恶性肿瘤新TNM分类的临床意义。
J Thorac Dis. 2018 Aug;10(Suppl 22):S2692-S2695. doi: 10.21037/jtd.2018.08.36.
7
Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.应用光子技术和粒子疗法的先进放疗方法在胸腺瘤术后管理中的剂量学比较。
Acta Oncol. 2018 Dec;57(12):1713-1720. doi: 10.1080/0284186X.2018.1502467. Epub 2018 Sep 28.
8
The expanding role of radiation therapy for thymic malignancies.放射治疗在胸腺恶性肿瘤治疗中不断扩大的作用。
J Thorac Dis. 2018 Aug;10(Suppl 21):S2555-S2564. doi: 10.21037/jtd.2018.01.154.
9
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.晚期胸腺癌的系统治疗:来自 RYTHMIC 前瞻性队列研究的见解。
J Thorac Oncol. 2018 Nov;13(11):1762-1770. doi: 10.1016/j.jtho.2018.08.005. Epub 2018 Aug 21.
10
Changing pattern of secondary cancers among patients with malignant thymoma in the USA.美国恶性胸腺瘤患者继发癌模式的变化。
Future Oncol. 2018 Aug;14(19):1943-1951. doi: 10.2217/fon-2017-0626. Epub 2018 Aug 7.